Paper40299459
Investigating the Prognostic Role of Telomerase-Related Cellular Senescence Gene Signatures in Breast Cancer Using Machine Learning.
Li Q and 1 other. Biomedicines, 2025. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Investigating the Prognostic Role of Telomerase-Related Cellular Senescence Gene Signatures in Breast Cancer Using Machine Learning. Papers, record 40299459. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40299459
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Investigating the Prognostic Role of Telomerase-Related Cellular Senescence Gene Signatures in Breast Cancer Using Machine Learning.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References88
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35145098 | Machine learning-based integration develops an immune-derived lncRNA signature for improving outcomes in colorectal cancer. | Nat Commun | 2022 | https://conductscience.org/library/papers/35145098 | PubMed |
| 2 | 24803582 | TP53 mutation spectrum in breast cancer is subtype specific and has distinct prognostic relevance. | Clin Cancer Res | 2014 | https://conductscience.org/library/papers/24803582 | PubMed |
| 3 | 11942415 | MAPK signal pathways in the regulation of cell proliferation in mammalian cells. | Cell Res | 2002 | https://conductscience.org/library/papers/11942415 | PubMed |
| 4 | 21558518 | A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer. | JAMA | 2011 | https://conductscience.org/library/papers/21558518 | PubMed |
| 5 | 28138400 | High expression of stromal PDGFRβ is associated with reduced benefit of tamoxifen in breast cancer. | J Pathol Clin Res | 2017 | https://conductscience.org/library/papers/28138400 | PubMed |
| 6 | 20098429 | Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancer. | Nat Med | 2010 | https://conductscience.org/library/papers/20098429 | PubMed |
| 7 | 33932560 | Tumor suppressor p53: Biology, signaling pathways, and therapeutic targeting. | Biochim Biophys Acta Rev Cancer | 2021 | https://conductscience.org/library/papers/33932560 | PubMed |
| 8 | 15591335 | A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. | N Engl J Med | 2004 | https://conductscience.org/library/papers/15591335 | PubMed |
| 9 | 30837677 | Exploiting heat shock protein expression to develop a non-invasive diagnostic tool for breast cancer. | Sci Rep | 2019 | https://conductscience.org/library/papers/30837677 | PubMed |
| 10 | 38412321 | Unlocking the potential of senescence-related gene signature as a diagnostic and prognostic biomarker in sepsis: insights from meta-analyses, single-cell RNA sequencing, and in vitro experiments. | Aging (Albany NY) | 2024 | https://conductscience.org/library/papers/38412321 | PubMed |
| 11 | 24406211 | The role of reactive oxygen species and metabolism on cancer cells and their microenvironment. | Semin Cancer Biol | 2014 | https://conductscience.org/library/papers/24406211 | PubMed |
| 12 | 33348826 | Machine Learning Algorithms to Predict Recurrence within 10 Years after Breast Cancer Surgery: A Prospective Cohort Study. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/33348826 | PubMed |
| 13 | 31485630 | Downregulation of transgelin 2 promotes breast cancer metastasis by activating the reactive oxygen species/nuclear factor‑κB signaling pathway. | Mol Med Rep | 2019 | https://conductscience.org/library/papers/31485630 | PubMed |
| 14 | 23746838 | The hallmarks of aging. | Cell | 2013 | https://conductscience.org/library/papers/23746838 | PubMed |
| 15 | 37827697 | ESICCC as a systematic computational framework for evaluation, selection, and integration of cell-cell communication inference methods. | Genome Res | 2023 | https://conductscience.org/library/papers/37827697 | PubMed |
| 16 | 9454329 | Telomeres and senescence: ending the debate. | Science | 1998 | https://conductscience.org/library/papers/9454329 | PubMed |
| 17 | 22763439 | Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion. | Nature | 2012 | https://conductscience.org/library/papers/22763439 | PubMed |
| 18 | 38001890 | HER-2 Expression in Colorectal Cancer and Its Correlation with Immune Cell Infiltration. | Biomedicines | 2023 | https://conductscience.org/library/papers/38001890 | PubMed |
| 19 | 10066087 | The relationship between prognostic and predictive factors in the management of breast cancer. | Breast Cancer Res Treat | 1998 | https://conductscience.org/library/papers/10066087 | PubMed |
| 20 | 36631400 | Evaluation oncotype DX® 21-gene recurrence score and clinicopathological parameters: a single institutional experience. | Histopathology | 2023 | https://conductscience.org/library/papers/36631400 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42179790 | Integrative Bulk and Single-Cell Transcriptome Profiling of Telomere-Related Genes Reveals a Robust Prognostic Signature and Immunotherapeutic Landscape in Neuroblastoma. | J Cancer | 2026 | https://conductscience.org/library/papers/42179790 | PubMed |
| 40781676 | Cellular senescence in cancer: from mechanism paradoxes to precision therapeutics. | Mol Cancer | 2025 | https://conductscience.org/library/papers/40781676 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40299459
GET https://conductscience.org/api/papers/v1/40299459/references?page=2